“Formulation and Evaluation of Novel Medicated Chewing Gum Loaded With Metoclopramide for Motion Sickness”
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: MYSORE PRAKASH, Gowrav (JSS COLLEGE OF PHARMACY, PHAMACEUTICS, MYSORE, India)
- Co-author(s): Gowrav Mysore Prakash: PHAMACEUTICS, JSS COLLEGE OF PHARMACY, MYSORE, India;PHAMACEUTICS, JSS COLLEGE OF PHARMACY, MYSORE, India
Vishekantegowda D: PHAMACEUTICS, JSS COLLEGE OF PHARMACY, MYSORE, India
Metoclopramide is a dopamine antagonist and widely used in the treatment of nausea and vomiting. The development of metoclopramide as medicated chewing gum (MCG) has potential advantages in terms of patient compliance, fast onset of action and improved bioavailability.
AimsFormulation, development of MCG of metoclopramide, optimization.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.